Roles & People
LP
Limited Partner — an investor in a venture capital fund who provides capital but has no role in investment decisions and whose liability is limited to their committed amount.
LP stands for Limited Partner — the institutional or individual investors who commit capital to a venture fund. LPs are the capital providers of the VC ecosystem; without them, no fund exists.
Common LP types: - University endowments (Yale, Harvard, Stanford) - Pension funds (CalPERS, Teacher Retirement Systems) - Sovereign wealth funds (GIC, Mubadala) - Fund-of-funds (HarbourVest, Adams Street) - Family offices (ultra-high-net-worth individuals) - Insurance companies - High-net-worth individuals (typically accredited investors) - Corporations (strategic LPs)
LPs have limited liability — they can lose their committed capital but are not personally liable for fund debts beyond that. They have no day-to-day role in investment decisions. Their relationship with the GP is governed by the Limited Partnership Agreement (LPA).
In exchange for their capital, LPs receive 80% of fund profits (the other 20% going to the GP as carried interest), plus the return of their committed capital.
In Practice
The Yale Endowment, managed by Yale's investment office, is one of the most prominent LPs in venture capital — famously allocating a large percentage of its portfolio to alternative assets including VC. When Yale commits $50M to a fund, it becomes a limited partner with contractual rights (information, distribution, advisory committee participation) but no voting rights on investments.
Why It Matters
LPs are the ultimate capital allocators in venture. Their preferences, risk tolerances, and return expectations shape what GPs can do — fund size, strategy, geography. Understanding the LP base of a fund helps explain its behavior: a pension fund LP needs liquidity; a family office may be more flexible. When a fund has LP pressure for distributions, that affects portfolio company outcomes including exit timing.
VC Beast Take
The LP/GP dynamic is a principal-agent relationship with imperfect information — LPs can't easily observe what GPs do with their capital until results come in, 7–10 years later. This is why LP due diligence on GPs is so intensive, and why GP track record and reputation matter so much. The best LPs are genuine partners: they provide patient capital, constructive feedback, and valuable introductions. The worst are purely financial — they'll pull capital the moment performance dips.